President Donald Trump has publicly blamed the Federal Reserve's interest rates hikes for holding back U.S. economic growth.The Fedread more
China's President Xi Jinping arrived in Pyongyang on Thursday morning for a state visit to North Korea — the first by a Chinese state leader in 14 years. Experts say the move...Asia Politicsread more
Gold prices spiked in the afternoon of Asian trading hours on Thursday after a dovish U.S Federal Reserve opened the door to further rate cuts, and the 10-year Treasury yield...Metalsread more
The Fed came very close to promising a rate cut Wednesday, and now markets are focused on a possible July rate cut.Market Insiderread more
Waymo has signed a deal with Renault and Nissan to develop self-driving cars and trucks for use in France, Japan and possibly other countries in Asia, including China, the...Autosread more
"No U.S. drone was operating in Iranian airspace today," a U.S. Central Command spokesman said, according to NBC News.World Politicsread more
The Fed left interest rates unchanged at its monetary policy meeting. The U.S. central bank did, however, drop the word "patient " from its statement and said it would "act as...Asia Marketsread more
As the presidents of U.S. and China near a highly anticipated meeting on trade, the gap in both sides' expectations regarding a deal remains wide.World Politicsread more
Markets had expected the central bank to keep its benchmark interest rate steady while setting up a cut at the July meeting.The Fedread more
The yield on the benchmark 10-year Treasury note fell below 2% for the first time since November 2016 on Wednesday.Bondsread more
Powell said policymakers are concerned about some of the recent economic developments and see a growing case for easier policy.The Fedread more
Baidu shares closed down almost 8 percent Monday after Chinese news outlet Sina reported the company's CEO, Robin Li, would be summoned by Chinese authorities over the death of a student.
China's Internet regulator said on Monday it would send an investigation team to Chinese search leader Baidu over the death of a university student, who had used the search engine to look for treatment for his cancer.
Wei Zexi, 21, died last month of a rare form of cancer.
He had turned to Baidu to look online for the best place for treatment, finding a department under the Second Hospital of Beijing Armed Police Corps that offered an experimental form of treatment that ultimately failed, according to state media.
Before dying, Wei had posted criticism online accusing Baidu of promoting false medical information, as well as the hospital for misleading advertising in claiming a high success rate for the experimental treatment, state radio said.
"Wei's family says they trusted the treatment because it was promoted by one of the military hospitals which are considered credible, and the attending doctor had appeared on many mainstream media platforms," state radio said.
The regulator said in a short statement Wei's case had attracted widespread attention on the internet.
It, along with the health ministry and State Administration for Industry and Commerce, would investigate Baidu over the case and "handle it in accordance with the law" and publicize its findings.
Shares in Baidu dropped 7.9 percent on the Nasdaq composite to $178.91 each after the reports surfaced, while the volume of options contracts traded was two-and-a-half times larger than usual, with sentiment heavily skewed toward bearish bets, Reuters reported, citing Trade Alert data.
Baidu said in a statement it deeply regretted Wei's death and sent its condolences to his family.
"Baidu strives to provide a safe and trustworthy search experience for our users, and have launched an immediate investigation of the matter," it said.
The company added it welcomed the investigation and would fully cooperate.
Internet portal Sina cited unidentified Baidu sources as saying the regulator had also asked to speak to the CEO, Li, but that the subject of the discussion wasn't clear.
Reuters was not able to reach the hospital for comment.
Baidu has been in trouble before for medical related issues.
This year, it was criticized for selling management rights for an online forum related to haemophilia to an unlicensed private hospital, which then used the platform for self-promotion and deleted comments that challenged its credentials, the official Xinhua news agency said.
In 2010, China's state-run television accused Baidu of promoting counterfeit drugs through its search engine.
— CNBC contributed to this report.